CIK 0001430306
- Non-accelerated filer
- Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261434750
- Phone
- +1 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Executive Officer bought 35,000 shares at $0.68 ($23,800)
- 4 Open-market buy Director bought 5,500 shares at $0.89 ($4,895)
- 4 Open-market buy Director bought 5,391 shares at $0.93 ($4,997)
- 4 Open-market buy Chief Medical Officer bought 20,000 shares at $1.03 ($20,600)
- 4 Open-market buy Director bought 4,500 shares at $1.06 ($4,770)
- 4 Open-market buy Director bought 5,350 shares at $0.94 ($5,029)
- 4 Open-market buy Chief Executive Officer bought 60,000 shares at $0.91 ($54,600)
- 4 Open-market buy Director bought 10,000 shares at $0.91 ($9,100)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 19 · 376 filings